Ads
related to: pfizer
Search results
US FDA grants full approval for Pfizer's cervical cancer drug
Reuters via Yahoo News· 5 minutes ago(Reuters) - The U.S. Food and Drug Administration granted traditional approval for Pfizer's drug for...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 4 hours agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 22 hours agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
Labcorp nets companion diagnostic approval for Pfizer’s hemophilia B gene therapy Beqvez
FierceBiotech· 2 hours agoThe FDA has bestowed a green light to a companion diagnostic forPfizer’s recently approved...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
13 Best Reddit Stocks to Buy Now
Insider Monkey via Yahoo Finance· 49 minutes agoIn this article, we will take a detailed look at the 13 Best Reddit Stocks to Buy Now. For a quick overview of such stocks, read our article 5 Best...
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 7 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 3 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
Earnings Calendar, Analyst Estimates And Stocks To Watch
Investor's Business Daily· 3 hours agoWhen searching for the best stocks to buy and watch, look for companies with strong earnings growth...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 1 day agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...